awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26822754-CCE13AA4-D768-402E-92D9-F1D6AB26DB2E
Q26822754-CCE13AA4-D768-402E-92D9-F1D6AB26DB2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26822754-CCE13AA4-D768-402E-92D9-F1D6AB26DB2E
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials
P2860
Q26822754-CCE13AA4-D768-402E-92D9-F1D6AB26DB2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26822754-CCE13AA4-D768-402E-92D9-F1D6AB26DB2E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7177f3523fec160bde3ef53876b3f8ec3ce6185
P2860
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells